March 17, 2020
C-Path to lead multi-stakeholder engagement to enhance the pediatric medical device ecosystem
Related Posts
-
Rare Diseases Cures Accelerator Data and Analytics Platform (RDCA-DAP) best practices and recommendations for FAIR data, toward alignment with International Regulatory agencies -
C-Path Appoints Health Outcomes Expert as Executive Director of the Rare Disease COA Consortium -
C-Path Launches Rare Disease Clinical Outcome Assessment Consortium
-
C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium -
DiMe Journal Club features Critical Path for Parkinson’s 3DT initiative